Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
CAH | CARDINAL HEALTH INC | Deborah Weitzman | CEO, PSS Segment | Aug 20, 2025 | Sale | $150.53 | 21,367 | 3,216,374 | 53,428 | Aug 20, 2025, 04:12 PM | |
CAH | CARDINAL HEALTH INC | Deborah Weitzman | CEO, PSS Segment | Aug 15, 2025 | Tax Payment (Shares) | $150.22 | 24,128 | 3,624,508 | 74,795 | Aug 19, 2025, 07:20 PM | |
CAH | CARDINAL HEALTH INC | Deborah Weitzman | CEO, PSS Segment | Dec 02, 2024 | Tax Payment (Shares) | $122.24 | 632 | 77,256 | 49,129 | Dec 03, 2024, 04:18 PM | |
CAH | CARDINAL HEALTH INC | Deborah Weitzman | CEO, PSS Segment | Aug 15, 2024 | Tax Payment (Shares) | $106.36 | 9,918 | 1,054,878 | 38,572 | Aug 19, 2024, 08:15 PM | |
CAH | CARDINAL HEALTH INC | Deborah Weitzman | CEO, PSS Segment | Aug 16, 2024 | Tax Payment (Shares) | $107.91 | 2,341 | 252,617 | 49,761 | Aug 19, 2024, 08:15 PM | |
CAH | CARDINAL HEALTH INC | Deborah Weitzman | CEO, Pharmaceutical Segment | Dec 01, 2023 | Tax Payment (Shares) | $107.08 | 638 | 68,317 | 34,564 | Dec 05, 2023, 04:42 PM | |
CAH | CARDINAL HEALTH INC | Deborah Weitzman | CEO, Pharmaceutical Segment | Nov 27, 2023 | Option/RSU Exercise | $74.10 | 27,642 | 2,048,356 | 71,844 | Nov 29, 2023, 09:14 AM | |
CAH | CARDINAL HEALTH INC | Deborah Weitzman | CEO, Pharmaceutical Segment | Nov 27, 2023 | Sale | $106.31 | 36,642 | 3,895,411 | 35,202 | Nov 29, 2023, 09:14 AM | |
CAH | CARDINAL HEALTH INC | Deborah Weitzman | CEO, Pharmaceutical Segment | Aug 28, 2023 | Option/RSU Exercise | $71.43 | 6,712 | 479,438 | 50,914 | Aug 29, 2023, 04:21 PM | |
CAH | CARDINAL HEALTH INC | Deborah Weitzman | CEO, Pharmaceutical Segment | Aug 28, 2023 | Sale | $89.81 | 6,712 | 602,805 | 44,202 | Aug 29, 2023, 04:21 PM | |
CAH | CARDINAL HEALTH INC | Deborah Weitzman | CEO, Pharmaceutical Segment | Aug 15, 2023 | Tax Payment (Shares) | $92.99 | 10,966 | 1,019,728 | 28,715 | Aug 17, 2023, 07:51 PM | |
CAH | CARDINAL HEALTH INC | Deborah Weitzman | CEO, Pharmaceutical Segment | Dec 01, 2022 | Tax Payment (Shares) | $80.17 | 380 | 30,465 | 26,921 | Dec 05, 2022, 04:29 PM |